Researchers at The University of Texas MD Anderson Cancer Center have identified an epigenetic target for replication stress, called DPY30, that could sensitize pancreatic tumors to immunotherapy and serve as a predictive biomarker for patients…
Continue Reading
News Source: medicalxpress.com
Leave a Reply